Page last updated: 2024-08-26

arsenic and ganciclovir

arsenic has been researched along with ganciclovir in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Block, GJ; Esteves, KC; Flemington, EK; Lasky, JA; Lin, Z; Shan, B; Sides, MD1
Flemington, EK; Lasky, JA; Lin, Z; Luo, F; Sides, MD; Sosulski, ML1

Other Studies

2 other study(ies) available for arsenic and ganciclovir

ArticleYear
Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells.
    Virology, 2011, Jul-20, Volume: 416, Issue:1-2

    Topics: Antiviral Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Drug Resistance, Viral; Epithelial Cells; Ganciclovir; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Humans; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Transcription Factors; Tumor Suppressor Proteins; Up-Regulation; Viral Matrix Proteins

2011
Co-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma.
    Virology journal, 2013, May-16, Volume: 10

    Topics: Animals; Antineoplastic Agents; Antiviral Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Disease Models, Animal; Drug Therapy, Combination; Ganciclovir; Heterografts; Humans; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oxides; Treatment Outcome; Tumor Burden

2013